HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could 5 radiation sessions be as good as 30 for skin cancer?
Disease control Recruiting nowThis study tests whether a shorter, more intense type of radiation (stereotactic radiotherapy given in 5 sessions) works as well as the standard longer course (20-30 sessions) for treating skin cancer that has spread to the parotid gland in the head and neck. About 90 adults who …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: David Palma • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New shot targets tough cancers: early trial opens
Disease control Recruiting nowThis early-phase study tests a new drug called SH009 in people with advanced solid tumors (like liver, lung, breast, or stomach cancer) that have not responded to standard treatments. The goal is to see if the drug is safe and can shrink tumors. About 150 adults will take part in…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug cocktail shows promise for tough head and neck cancers
Disease control Recruiting nowThis study tests a new combination of drugs given before surgery for people with advanced head and neck cancer. The goal is to see if this treatment can shrink tumors more effectively, potentially making surgery easier or even possible for some. About 76 adults with stage III-IV …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC
-
New combo therapy aims to shrink head and neck tumors
Disease control Recruiting nowThis study tests whether adding the experimental drug VS-101 to standard chemoradiotherapy helps control head and neck cancer better than standard treatment alone. About 30 adults with squamous cell carcinoma of the mouth, throat, or voice box will be randomly assigned to one of …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: VSPharmTech Co.,Ltd. • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC